Açıklama
Study protocol timeline for the trial evaluating continuous consumption of fermented milk containing Bifidobacterium bifidum YIT 10347 in patients with functional gastrointestinal symptoms.
More Figures from This Paper
Figure 2
Gastrointestinal symptom scores over time in patients consuming Bifidobacterium bifidum YIT 10347-containing fermented milk, tracking improvements in dyspepsia and related complaints.
chart
Figure 3
Psychological symptom assessments in patients with functional gastrointestinal disorders during the probiotic fermented milk intervention period.
chart
Figure 4
Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration changes over time, reflecting oxidative stress levels during Bifidobacterium bifidum YIT 10347 supplementation.
chartFigure 1
Flowchart
534 × 202px
· 4,5 KB
Source Paper
Continuous consumption of fermented milk containing Bifidobacterium bifidum YIT 10347 improves gastrointestinal and psychological symptoms in patients with functional gastrointestinal …Cite This Figure
 > Source: Yoshihisa Urita et al. "Continuous consumption of fermented milk containing Bifidobacterium bifidum YIT ." *Bioscience of microbiota, food and health*, 2015. PMID: [25918671](https://pubmed.ncbi.nlm.nih.gov/25918671/)
<figure> <img src="https://pdfs.citedhealth.com/figures/25918671/59.png" alt="Study protocol timeline for the trial evaluating continuous consumption of fermented milk containing Bifidobacterium bifidum YIT 10347 in patients with functional gastrointestinal symptoms." /> <figcaption>Figure 1. Study protocol timeline for the trial evaluating continuous consumption of fermented milk containing Bifidobacterium bifidum YIT 10347 in patients with functional gastrointestinal symptoms.<br> Source: Yoshihisa Urita et al. "Continuous consumption of fermented milk containing Bifidobacterium bifidum YIT ." <em>Bioscience of microbiota, food and health</em>, 2015. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/25918671/">25918671</a></figcaption> </figure>